Furthermore, significantly higher concentrations of beta-catenin were identified in the kidneys of the CIS-treated Gal-3 wild-type mice compared to the CIS-treated Gal-3 KO mice, showing statistical significance (p < 0.01) (Figure 11B). This evidence concerns the gene LGALS3 and in situ carcinoma.